Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 117-121

  Achour, Wafa ^a   Guenni, Olfa ^a   Malbruny, Brigitte ^b   Canu, Annie ^b   Leclercq, Roland ^b   Hassen, Assia Ben ^a  

^a CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^b CHU CÔTE DE NACRE   (France)

Author keywords

Drug resistance; Mutation; Oral streptococci; Ribosome

Indexed keywords

ALANINE; AMPICILLIN; CARRIER PROTEIN; ERYTHROMYCIN; GENTAMICIN; GLYCINE; LINCOMYCIN; MACROLIDE; METHYLTRANSFERASE; PENICILLIN G; PRISTINAMYCIN; RIBOSOME PROTEIN; SPIRAMYCIN; STREPTOGRAMIN; TEICOPLANIN; VANCOMYCIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MECHANICS; NEUTROPENIA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; TUNISIA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BONE MARROW TRANSPLANTATION; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NEUTROPENIA; PHENOTYPE; PRISTINAMYCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS; STREPTOGRAMINS;

EID: 3543109637     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh317     Document Type: Article

References (25)

1. Teng, L., Hsueh, P., Chen, Y. et al. (1998). Antimicrobial susceptibility of viridans group streptococci in Taiwan with emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. Journal of Antimicrobial Chemotherapy 41, 621-7.
2. Bryskier, A. (2002). Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clinical Microbiology and Infection 2, 65-9.
3. Bogaert, D., Hermans, P. W., Grivea, I. N. et al. (2003). Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children. Journal of Clinical Microbiology 41, 5633-9.
4. Leclercq, R. & Courvalin, P. (2002). Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, 2727-34.
5. Clancy, J., Petitpas, J., Dib-Hajj, F. et al. (1996). Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Molecular Microbiology 22, 867-79.
6. Canu, A. & Leclercq, R. (2001). Overcoming bacterial resistance by dual target inhibition: the case of streptogramins. Current Drug Targets Infectious Disorders 1, 215-25.
7. Canu, A., Malbruny, B., Coquemont, M. et al. (2002). Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, 125-31.
8. Jones, R. N., Farrell, D. J. & Morrissey, I. (2003). Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program. Antimicrobial Agents and Chemotherapy 47, 2696-8.
9. Angot, P., Vergnaud, M., Auzou, M. et al. (2000). Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. European Journal of Clinical Microbiology and Infectious Diseases 19, 755-8.
10. Bozdogan, B. & Leclercq, R. (1999). Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrobial Agents and Chemotherapy 43, 2720-5.
11. Members of the SFM Antibiogram Committee (2003). Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. International Journal of Antimicrobial Agents 21, 364-91.
12. Poyart-Salmeron, C., Trieu-Cuot, P., Carlier, C. et al. (1991). Nucleotide sequences specific for Tn1545-like conjugative transposons in pneumococci and staphylococci resistant to tetracycline. Antimicrobial Agents and Chemotherapy 35, 1657-60.
13. Doern, G. V., Ferrero, M. J., Brueggemann, A. B. et al. (1996). Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrobial Agents and Chemotherapy 42, 891-4.
14. Wisplinghoff, H., Reinert, R., Comely, O. et al. (1999). Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolates from blood of neutropenic cancer patients. Journal of Clinical Microbiology 37, 1876-80.
15. Ioannidou, S., Tassios, P. T., Kotsovili-Tseleni, A. et al. (2001). Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. International Journal of Antimicrobial Agents 17, 195-201.
16. Alcaide, F., Carratala, J., Linares, J. et al. (1996). In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrobial Agents and Chemotherapy 40, 2117-20.
17. Teng, L., Hsueh, P., Chen, Y. et al. (1998). Antimicrobial susceptibility of viridans group streptococci in Taiwan with emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. Journal of Antimicrobial Chemotherapy 41, 621-7.
18. Seppälä, H., Haanpera, M., Al-Juhaish, M. et al. (2003). Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. Journal of Antimicrobial Chemotherapy 52, 636-44.
19. Perez-Trallero, E., Vincente, D., Montes, M. et al. (2001). High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. Journal of Antimicrobial Chemotherapy 48, 225-9.
20. Aracil, B., Minambres, M., Oteo, J. et al. (2001). High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. Journal of Antimicrobial Chemotherapy 48, 592-4.
21. Ono, T., Shiota, S., Hirota, K. et al. (2000). Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrobial Agents and Chemotherapy 44, 1078-80.
22. Poutanen, S. M., De Azavedo, J., Willey, B. M. et al. (1999). Molecular characterization of multidrug resistance in Streptococcus mitis. Antimicrobial Agents and Chemotherapy 43, 1505-7.
23. De Mouy, D., Cavallo, J. D., Leclercq, R. et al. (2001). Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicentre study. Antimicrobial Agents and Chemotherapy 45, 2400-2.
24. Culberas, E., Rodriguez-Avial, I., Betriu, C. et al. (2002). Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrobial Agents and Chemotherapy 46, 1574-6.
25. Malbruny, B., Canu, A., Bozdogan, B. et al. (2002). Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 46, 2200-7.